RedHill Biopharma (RDHL) Return on Sales Growth (1y) (2013 - 2023)
RedHill Biopharma (RDHL) Return on Sales Growth (1y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 0.00 |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 0.00 |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -1.00 |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn | 0.00 |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn | 1.00 |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 0.00 |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn | 0.00 |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 32.00 |
| Mar 31, 2023 | -3.00 |
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | -2.00 |
| Jun 30, 2022 | -1.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -7.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 1.00 |
| Mar 31, 2021 | -15.00 |
| Dec 31, 2020 | -6.00 |
| Sep 30, 2020 | -7.00 |
| Jun 30, 2020 | -9.00 |
| Mar 31, 2020 | 11.00 |
| Dec 31, 2019 | -2.00 |
| Sep 30, 2019 | 3.00 |
| Jun 30, 2019 | 6.00 |
| Mar 31, 2019 | 1.00 |
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | -4.00 |